BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26609896)

  • 1. Work ability in prostate cancer survivors after radical prostatectomy.
    Dahl S; Cvancarova M; Dahl AA; Fosså SD
    Scand J Urol; 2016; 50(2):116-22. PubMed ID: 26609896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Return to work and sick leave after radical prostatectomy: a prospective clinical study.
    Dahl S; Steinsvik EA; Dahl AA; Loge JH; Cvancarova M; Fosså SD
    Acta Oncol; 2014 Jun; 53(6):744-51. PubMed ID: 24195691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical prostatectomy for clinical T4 prostate cancer.
    Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
    Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy.
    Adam M; Tennstedt P; Lanwehr D; Tilki D; Steuber T; Beyer B; Thederan I; Heinzer H; Haese A; Salomon G; Budäus L; Michl U; Pehrke D; Stattin P; Bernard J; Klaus B; Pompe RS; Petersen C; Huland H; Graefen M; Schwarz R; Huber W; Loeb S; Schlomm T
    Eur Urol; 2017 Mar; 71(3):330-336. PubMed ID: 27887941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer.
    Westover K; Chen MH; Moul J; Robertson C; Polascik T; Dosoretz D; Katin M; Salenius S; D'Amico AV
    BJU Int; 2012 Oct; 110(8):1116-21. PubMed ID: 22540922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter?
    Hsu CC; Paciorek AT; Cooperberg MR; Roach M; Hsu IC; Carroll PR
    BJU Int; 2015 Nov; 116(5):713-20. PubMed ID: 25600860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does a surgeon's annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? Findings from a prospective national study.
    Steinsvik EA; Axcrona K; Angelsen A; Beisland C; Dahl A; Eri LM; Haug ES; Svindland A; Fosså S
    Scand J Urol; 2013 Apr; 47(2):92-100. PubMed ID: 22860630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Work status and work ability after radical prostatectomy or active surveillance for prostate cancer.
    Nilsson R; Dahl AA; Bernklev T; Kersten H; Haug ES
    Scand J Urol; 2020 Jun; 54(3):194-200. PubMed ID: 32285740
    [No Abstract]   [Full Text] [Related]  

  • 10. Early salvage radiation therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical prostatectomy: single-institution 4-year data on outcome, toxicity, health-related quality of life and co-morbidities from 184 consecutive patients treated with 70 Gy.
    Cortés-González JR; Castellanos E; Sandberg K; Eriksson MH; Wiklund P; Carlsson S; Cohn-Cedermark G; Harmenberg U; Gustafsson O; Levitt SH; Lennernäs B; Brandberg Y; Márquez M; Kälkner KM; Nilsson S
    Int J Oncol; 2013 Jan; 42(1):109-17. PubMed ID: 23151842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour characteristics, oncological and functional outcomes in patients aged ≥ 70 years undergoing radical prostatectomy.
    Kunz I; Musch M; Roggenbuck U; Klevecka V; Kroepfl D
    BJU Int; 2013 Mar; 111(3 Pt B):E24-9. PubMed ID: 22947135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial.
    Pearse M; Fraser-Browne C; Davis ID; Duchesne GM; Fisher R; Frydenberg M; Haworth A; Jose C; Joseph DJ; Lim TS; Matthews J; Millar J; Sidhom M; Spry NA; Tang CI; Turner S; Williams SG; Wiltshire K; Woo HH; Kneebone A
    BJU Int; 2014 Mar; 113 Suppl 2():7-12. PubMed ID: 24894850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery.
    Dahl S; Loge JH; Berge V; Dahl AA; Cvancarova M; Fosså SD
    J Cancer Surviv; 2015 Jun; 9(2):172-9. PubMed ID: 25216609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of prostate cancer patients following radiation therapy after radical surgery referred from urology to radiation oncology departments in Spain.
    Gómez Caamaño A; Zapatero A; López Torrecilla J; Maldonado X
    Clin Transl Oncol; 2016 Sep; 18(9):884-92. PubMed ID: 26621508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-prostatectomy radiotherapy adversely affects urinary continence irrespective of radiotherapy regime.
    Nyarangi-Dix JN; Steimer J; Bruckner T; Jakobi H; Koerber SA; Hadaschik B; Debus J; Hohenfellner M
    World J Urol; 2017 Dec; 35(12):1841-1847. PubMed ID: 28861691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of radical prostatectomy versus external beam radiotherapy (75.6 Gy) combined with hormone therapy for prostate cancer of intermediate D'Amico risk classification].
    Boissier R; Karsenty G; Muracciole X; Daniel L; Delaporte V; Maurin C; Coulange C; Lechevallier E
    Prog Urol; 2013 Sep; 23(10):861-8. PubMed ID: 24034798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy.
    Cheung R; Kamat AM; de Crevoisier R; Allen PK; Lee AK; Tucker SL; Pisters L; Babaian RJ; Kuban D
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):134-40. PubMed ID: 16111581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.